Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data XORTX Therapeutics Inc. files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
Research and development
0.04
0.28
0.85
General and administrative
0
Pre-tax income
-0.57
-1.4
-3.65
Net income
-0.63
-1.28
-1.65
Balance sheet
FY2019
FY2021
FY2021
Cash and equivalents
0.06
0.17
18.9
Total current assets
2.06
20.2
Total assets
2.29
22
Total current liabilities
1.03
0.7
Total liabilities
1.03
5.3
Retained earnings
-8.04
-9.69
Shareholders' equity
1.26
16.7
Total equity
-0.21
1.26
16.7
Total liabilities and equity
2.29
22
Cash flow statement
FY2019
FY2021
FY2021
Net income
-0.63
-1.28
-1.65
Depreciation and amortization
0.02
0.02
0.02
Cash from operations
-0.25
-0.73
-6.06
Cash from financing
0.06
0.86
24.5
Exchange rate effect
0.33
Net change in cash
-0.2
0.11
18.7
Key metrics
Worked out from the statements above. Latest values use fiscal 2021. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-18.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-13.6%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
1,232.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
862.1%
Total assets vs the same period a year earlier. Only from a positive base.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
28.8x
Current assets / current liabilities.
Quick ratio
26.9x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
26.9x
(Cash + short-term investments) / current liabilities.
Was XORTX Therapeutics Inc. profitable in fiscal 2021?
No. It reported a net loss of CA$1.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.